Contact

Click here for a confidential contact or call:

1-212-350-2774

FCA Federal

This archive displays posts tagged as relevant to the federal False Claims Act. You may also be interested in the following pages:

Page 133 of 182

Two State Social Services Departments Settle FCA Suits over SNAP Funds

Posted  04/13/17
By the C|C Whistleblower Lawyer Team This week, the Virginia Department of Social Services (VDSS) and the Wisconsin Department of Health Services (WDHS) each agreed to pay the United States roughly $7M to settle allegations that they violated the FCA in their administrations of the SNAP program (formerly known as the Food Stamp program). Both VDSS and WDHS used the same consultant, Julie Osnes Consulting, to advise...

Fifth Circuit Applies “Demanding” Escobar Materiality Standard

Posted  04/5/17
By Rosie Dawn Griffin The Supreme Court’s holding in Universal Health Services, Inc. v. United States ex rel. Escobar continues to be hashed out in the lower courts. Last month, the Fifth Circuit applied Escobar’s materiality standard in U.S. ex rel Abbott et al. v. BP Exploration and Production, Inc. et al., a whistleblower case former BP contractor Kenneth Abbott brought under the False Claims Act (FCA) in...

March 10, 2017

New York based information technology management software company CA Inc. agreed to pay $45 million to resolve allegations it violated the False Claims Act by making false claims in the negotiation and administration of a General Services Administration contract.  According to the government, CA provided false information about the discounts it gave commercial customers for its software licenses and maintenance services at the time the contract was negotiated and also violated the price reduction clause in the contract by not providing government customers with additional discounts when commercial discounts improved.  The allegations originated a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by Dani Shemesh, a former employee of CA Software Israel LTD.  Shemesh will receive a whistleblower award of roughly $10.2 million from the proceeds of the government's recovery. DOJ

March 1, 2017

ATCH, LLC (d/b/a G-MART) and ALI ASGHAR KHAN agreed to pay $65,000 to settle allegations they violated the False Claims Act by submitting false claims under the Supplemental Nutrition Assistance Program to the Department of Agriculture, Food and Nutrition Service which was established to provide food to low-income individuals through approved retail food stores. DOJ (WDOK)

March 1, 2017

Florida-based information technology company People, Technology and Processes, LLC and the company's CEO and CFO, Victor Buonamia and Nicole Buonamia, agreed to pay $320,000 to resolve allegations they violated the False Claims Act by submitting improper invoices for work allegedly performed for the United States in support of the U.S. Army in Afghanistan.  The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by former company employee Aidan Tamer Toprakci.  He will receive a whistleblower award of roughly $64,000 from the proceeds of the government's recovery. DOJ (MDFL)

February 28, 2017

CH2M Hill, Inc. agreed to pay $1.5 million to settle charges of violating the False Claims Act by overbilling the government under a Joint Venture Project Management Oversight Agreement with Amtrak. DOJ

DOJ intervenes in $50 Million Healthcare Fraud Case

Posted  03/2/17
By the C|C Whistleblower Lawyer Team Preet Bharara, US Attorney for the Southern District of New York, announced a civil suit and criminal actions against several doctors and health care entities alleging over $50M in fraud through schemes that lasted over 12 years. Five of the six doctors charged in their personal capacity were arrested in the New York area on Wednesday. The allegations center around Asim...

February 16, 2017

New Jersey doctor Kenneth D. Nahmu, his wife Ann Walsh and their oncology practice agreed to pay $1.7 million to resolve allegations they violated the False Claims Act by billing Medicare for illegally importing and using unapproved chemotherapy drugs from foreign distributors.  DOJ (DNJ)

February 15, 2017

Nevada-based Sierra Nevada Corporation agreed to pay $14.9 million to resolve allegations it violated the False Claims Act by misclassifying certain costs, resulting in inflated overhead rates paid to the company under various government contracts.  DOJ (EDCA)
1 131 132 133 134 135 182